Tumor site immune markers associated with risk for subsequent basal cell carcinomas - Wikidata - wikimedia - TriplyDB

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

http://www.wikidata.org/entity/Q34042944

about

Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinoma Gender specific association of child abuse and adult cardiovascular disease in a sample of patients with basal cell carcinoma.Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.Understanding the Molecular Genetics of Basal Cell Carcinoma.

P2860

Q28074335-BC5D5868-E0AB-49C4-8B75-8D2D72B24CF7 Q37215888-FDA56101-9A49-4635-BCE0-F0721709CC6B Q37354574-A29DE5EE-ED6B-4CB7-B33C-054B4AF3B810 Q41494871-A69166E1-24D8-481F-9239-09DEBC4D941B Q47108777-82811F2D-C78B-480A-86AA-15BF7653800C

P2860

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

http://www.wikidata.org/entity/Q34042944

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@ast

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@en

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@nl

type

label

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@ast

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@en

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@nl

prefLabel

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@ast

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@en

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@nl

P1433

Q34042944-6EB5D994-273B-4101-A91C-D9C55DE59B22

P1476

Q34042944-861BF3EF-C4C6-421C-B272-52CC7F71B43B

P2093

Q34042944-0370C146-7B2B-4B18-8CC7-16E1C82C9447

Q34042944-1EA2D6A0-B655-4DD5-9C7C-E3B3F4113FBF

Q34042944-23773818-16A1-4875-8765-AD3206C22ABA

Q34042944-464DE306-B8C0-4304-AC0C-4CAB21DA4941

Q34042944-542E2EB4-21AE-4BD7-9CCA-3D0BCF70564B

Q34042944-600FB1E9-4ECC-494F-BEA9-14078DDC103E

Q34042944-6EFD1AE7-1E77-4916-97C8-B8AC3F261A25

Q34042944-D199D9A2-97AD-419E-A30E-2FFB422B2105

Q34042944-E95CE003-83AB-4696-8A30-D29354B7BDDB

Q34042944-EC943561-B2D2-403F-B434-F9EF2323DB8D

P2860

Q34042944-013EC81D-84F5-4409-9786-12171E54F155

Q34042944-02D96EEC-8E59-4158-A454-831F34D6FAF1

Q34042944-06B1AFE2-B9C7-4EC3-9658-28CCF807C635

Q34042944-08B13DA0-A414-40E9-BAEF-E9284360C2BD

Q34042944-2090137E-B698-4B2B-84F7-F606408F7A1E

Q34042944-29D22D1D-1331-4370-8A18-D6971248A4FC

Q34042944-2EA7A7C7-4882-45A0-A682-DB09DDB898E4

Q34042944-2EAAF953-155F-4A42-94E0-79C3C8DCF0DD

Q34042944-336D15C8-3A8C-4D8B-883B-0B521C27A377

Q34042944-3B4E17F5-DA8A-411A-BCC9-3DEADBCFE092

P304

Q34042944-E3290285-70CF-4F6D-890B-1BB6B53E3518

P31

Q34042944-17845EC6-B565-4FEC-ABE4-CCB0F0FA126A

P356

Q34042944-3E9017AF-98D6-497B-A02F-369CA1AC7BF4

P407

Q34042944-C5E403F3-57DC-4CAD-82FE-DD6D09E2F8B3

P433

Q34042944-C4FB9F92-3136-47F7-980B-DEEA4CBFCC87

P478

Q34042944-A5A16A83-EFDA-4DD3-A74E-4464DCB3B60A

P50

Q34042944-0A0059C4-F09E-43DF-93A6-730A568FB172

Q34042944-8497CA43-6FA0-48D7-AADC-A6D4846EFD07

Q34042944-B6D4F38C-401E-471D-BDF3-B665F40B341A

P577

Q34042944-EC3F723B-F458-47C3-9DB8-2ED80CF70D3F

P5875

Q34042944-610C769B-E679-4446-AE07-EC3107355D8F

P698

Q34042944-3A397FF1-F1E4-4694-AB40-63D2EB0C6DEE

P932

Q34042944-D1553F3F-1071-4158-80E7-08C869E0C185

P356

JOURNAL.PONE.0025160

P1433

P1476

Tumor site immune markers associated with risk for subsequent basal cell carcinomas

@en

P2093

Arwa Y Shana'ah

http://www.w3.org/2001/XMLSchema#string

David R Lambert

http://www.w3.org/2001/XMLSchema#string

Dean W Hearne

http://www.w3.org/2001/XMLSchema#string

Eric V Yang

http://www.w3.org/2001/XMLSchema#string

Joel Bain Herron

http://www.w3.org/2001/XMLSchema#string

Lawrence A De Renne

http://www.w3.org/2001/XMLSchema#string

Mark A Bechtel

http://www.w3.org/2001/XMLSchema#string

Michael Di Gregorio

http://www.w3.org/2001/XMLSchema#string

Min Chen

http://www.w3.org/2001/XMLSchema#string

Ronald Glaser

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle

Ultraviolet radiation-induced tolerance.

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.

Basal cell carcinoma: from the molecular understanding of the pathogenesis to targeted therapy of progressive disease.

A nervous breakdown in the skin: stress and the epidermal barrier.

Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland

Melanoma and nonmelanoma skin cancers and the immune system.

The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure.

Spontaneous regression of two giant basal cell carcinomas in a single patient after incomplete excision.

P304

e25160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0025160

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Rebecca Andridge

Sheri L Johnson

Janice Kiecolt-Glaser

P577

2011-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51700054

http://www.w3.org/2001/XMLSchema#string

P698

21980389

http://www.w3.org/2001/XMLSchema#string

P932

3182995

http://www.w3.org/2001/XMLSchema#string